LVV-hemorphin-7 lowers blood pressure in spontaneously hypertensive rats: radiotelemetry study

Physiol Res. 2004;53(6):603-7.

Abstract

Cardiovascular effects of LVV-hemorphin-7, a member of the family of fragments from beta-chain of human or bovine hemoglobin, were studied in conscious spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats by radiotelemetry. Intraperitoneal injection of hemorphin in a dose of 100 microg/kg significantly decreased blood pressure in SHR, whereas negligible effect was seen in normotensive WKY rats. Blood pressure changes were accompanied by reduction of heart rate. In conclusion, a direct effect of LVV-hemorphin-7 on blood pressure was demonstrated in SHR. These biologically active peptides could be involved in blood pressure regulation especially in hypertensive rats, but the precise mechanism should be elucidated.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Heart Rate / drug effects*
  • Hemoglobins / administration & dosage*
  • Hypertension / physiopathology*
  • Male
  • Peptide Fragments / administration & dosage*
  • Rats
  • Rats, Inbred WKY
  • Rats, Wistar
  • Telemetry / methods

Substances

  • Hemoglobins
  • Peptide Fragments
  • LVV-hemorphin-7